Trademark: 87335713
Word
XERTESA
Status
Dead
Status Code
606
Status Date
Monday, October 12, 2020
Serial Number
87335713
Mark Type
4000
Filing Date
Tuesday, February 14, 2017
Published for Opposition
Tuesday, July 11, 2017
Abandoned Date
Monday, October 12, 2020

Trademark Owner History
Allergan Sales, LLC - Owner At Publication

Classifications
5 Pharmaceutical preparations used in connection with anti-aging, namely, for use in the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin; Pharmaceutical preparations used in connection with and for facial aesthetic surgery, facial aesthetic reconstruction, and breast aesthetic treatment procedures; topical antibiotics, anti-inflammatory, anti-infective, anti-glaucoma agents and decongestant formulations; sterile antibiotic ointments; ocular contact lens wetting solutions, artificial tears and pharmaceutical preparations for the treatment of minor ocular inflammations and allergic conditions; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lightener lotions and creams; Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing pharmaceutical preparations; Pharmaceutical preparations and medicines for the treatment and prevention of sexual dysfunction; Pharmaceutical preparations and medicines for the treatment of sensory organ disorders; Pharmaceutical preparations and medicines for the treatment of urogenital organ disorders; Pharmaceutical preparations and medicines for the treatment of circulatory system disorders; Pharmaceutical preparations and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism; Pharmaceutical and cosmeceutical preparations for skin care, namely, medicated skin cleansers, toners, moisturizers, rejuvenators, rehydrating creams, and lotions for the face and body
The word "XERTESA" has no meaning in a foreign language.

Trademark Events
Oct 13, 2020
Abandonment Notice E-Mailed - No Use Statement Filed
Oct 12, 2020
Abandonment - No Use Statement Filed
Mar 10, 2020
Notice Of Approval Of Extension Request E-Mailed
Mar 9, 2020
Extension 5 Granted
Feb 28, 2020
Extension 5 Filed
Mar 9, 2020
Case Assigned To Intent To Use Paralegal
Feb 28, 2020
Teas Extension Received
Jul 17, 2019
Notice Of Approval Of Extension Request E-Mailed
Jul 15, 2019
Extension 4 Granted
Jul 15, 2019
Extension 4 Filed
Jul 15, 2019
Teas Extension Received
Feb 16, 2019
Notice Of Approval Of Extension Request E-Mailed
Feb 14, 2019
Extension 3 Granted
Feb 14, 2019
Extension 3 Filed
Feb 14, 2019
Teas Extension Received
Sep 6, 2018
Notice Of Approval Of Extension Request E-Mailed
Sep 4, 2018
Extension 2 Granted
Sep 4, 2018
Extension 2 Filed
Sep 4, 2018
Teas Extension Received
Jan 25, 2018
Notice Of Approval Of Extension Request E-Mailed
Jan 23, 2018
Extension 1 Granted
Jan 23, 2018
Extension 1 Filed
Jan 23, 2018
Teas Extension Received
Sep 5, 2017
Noa E-Mailed - Sou Required From Applicant
Jul 11, 2017
Official Gazette Publication Confirmation E-Mailed
Jul 11, 2017
Published For Opposition
Jun 21, 2017
Notification Of Notice Of Publication E-Mailed
May 12, 2017
Approved For Pub - Principal Register
May 12, 2017
Examiner's Amendment Entered
May 12, 2017
Notification Of Examiners Amendment E-Mailed
May 12, 2017
Examiners Amendment E-Mailed
May 12, 2017
Examiners Amendment -Written
May 9, 2017
Assigned To Examiner
Feb 21, 2017
New Application Office Supplied Data Entered In Tram
Feb 17, 2017
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24